糖皮质激素治疗后的骨质流失。 - Suppr

Suppr

超能文献

Bone loss after glucocorticoid therapy.

作者信息

Lo Cascio V, Bonucci E, Imbimbo B, Ballanti P, Tartarotti D, Galvanini G, Fuccella L, Adami S

出版信息

Calcif Tissue Int. 1984 Jul;36(4):435-8. doi: 10.1007/BF02405356.

DOI:10.1007/BF02405356

PMID:6435841

Abstract

摘要

相似文献

Bone loss after glucocorticoid therapy.糖皮质激素治疗后的骨质流失。

Calcif Tissue Int. 1984 Jul;36(4):435-8. doi: 10.1007/BF02405356.

Does alternate-day cloprednol therapy prevent bone loss? A longitudinal double-blind, controlled clinical study.隔日使用氯泼尼醇疗法能否预防骨质流失？一项纵向双盲对照临床研究。

Clin Pharmacol Ther. 1990 Oct;48(4):455-66. doi: 10.1038/clpt.1990.175.

Effects of prednisone and deflazacort on vertebral bone mass.

Calcif Tissue Int. 1985 Dec;37(6):592-3. doi: 10.1007/BF02554912.

Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.肾病患者腰椎、前臂和下颌骨的糖皮质激素诱导性骨质疏松症：一项关于泼尼松与地夫可特高剂量、长期疗效的双盲研究。

Calcif Tissue Int. 1992 Jun;50(6):490-7. doi: 10.1007/BF00582160.

Acute effects of deflazacort and prednisone on rates of mineralization and bone formation.地夫可特和泼尼松对矿化率和骨形成的急性影响。

Calcif Tissue Int. 1995 Feb;56(2):109-12. doi: 10.1007/BF00296340.

Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.地夫可特与泼尼松治疗巨细胞动脉炎患者：对骨质流失的影响

J Rheumatol. 2001 Nov;28(11):2474-9.

Acute changes in urinary radiocalcium following glucocorticoids administration in man.人类服用糖皮质激素后尿放射性钙的急性变化。

Adv Exp Med Biol. 1984;171:407-15.

Practice patterns in patients at risk for glucocorticoid-induced osteoporosis.糖皮质激素性骨质疏松症高危患者的实践模式

Osteoporos Int. 2005 Dec;16(12):2168-74. doi: 10.1007/s00198-005-2016-z. Epub 2005 Sep 3.

Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment.接受每日糖皮质激素治疗的杜氏肌营养不良患者多学科管理的长期结果

J Pediatr. 2017 Mar;182:296-303.e1. doi: 10.1016/j.jpeds.2016.11.078. Epub 2016 Dec 30.

Prednisone-induced bone loss in sarcoidosis: a risk especially frequent in postmenopausal women.泼尼松诱发的结节病骨质流失：一种在绝经后女性中尤为常见的风险。

Sarcoidosis. 1988 Sep;5(2):93-8.

引用本文的文献

Bone Mineral Density Assessment by Quantitative Computed Tomography in Glucocorticoid-Treated Boys With Duchenne Muscular Dystrophy: A Linear Mixed-Effects Modeling Approach.基于线性混合效应模型探讨糖皮质激素治疗的杜氏肌营养不良症男孩的骨密度定量计算机断层扫描评估

Front Endocrinol (Lausanne). 2022 Mar 23;13:860413. doi: 10.3389/fendo.2022.860413. eCollection 2022.

Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros.双膦酸盐类药物治疗糖皮质激素性骨质疏松症：优势

Endocrine. 2015 Aug;49(3):620-7. doi: 10.1007/s12020-014-0506-5. Epub 2015 Feb 4.

Glycyrrhizic acid (GCA) as 11β-hydroxysteroid dehydrogenase inhibitor exerts protective effect against glucocorticoid-induced osteoporosis.甘草酸（GCA）作为 11β-羟甾体脱氢酶抑制剂对糖皮质激素诱导的骨质疏松症发挥保护作用。

J Bone Miner Metab. 2013 May;31(3):262-73. doi: 10.1007/s00774-012-0413-x. Epub 2012 Dec 30.

Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits.自1999年以来的无类固醇免疫抑制：129例小儿肾移植，移植肾和患者均持续受益。

Am J Transplant. 2009 Jun;9(6):1362-72. doi: 10.1111/j.1600-6143.2009.02640.x. Epub 2009 May 13.

Steroid elimination-who, when, how?类固醇消除——何人、何时、如何进行？

Transplant Proc. 2008 Dec;40(10 Suppl):S52-6. doi: 10.1016/j.transproceed.2008.10.007.

Minimization of steroids in kidney transplantation.肾移植中类固醇的最小化

Transpl Int. 2009 Jan;22(1):38-48. doi: 10.1111/j.1432-2277.2008.00728.x. Epub 2008 Jul 24.

Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis.降钙素用于治疗和预防糖皮质激素诱导的骨质疏松症。

Cochrane Database Syst Rev. 2000;2000(2):CD001983. doi: 10.1002/14651858.CD001983.

Prevention and treatment of postmenopausal osteoporosis.

Pharm World Sci. 1998 Oct;20(5):198-205. doi: 10.1023/a:1008682921480.

Sequential study of bone mineral density in patients with systemic lupus erythematosus.系统性红斑狼疮患者骨矿物质密度的序贯研究。

Ann Rheum Dis. 1996 Nov;55(11):857. doi: 10.1136/ard.55.11.857-a.

Deflazacort. A review of its pharmacological properties and therapeutic efficacy.地夫可特。其药理特性与治疗效果综述。

Drugs. 1995 Aug;50(2):317-33. doi: 10.2165/00003495-199550020-00008.

本文引用的文献

Fractures in Still's disease.斯蒂尔病中的骨折。

Ann Rheum Dis. 1960 Jun;19(2):135-42. doi: 10.1136/ard.19.2.135.

Vertebral fractures resulting from prolonged cortisone and corticotropin therapy.长期使用可的松和促肾上腺皮质激素治疗导致的椎体骨折。

J Am Med Assoc. 1954 Oct 2;156(5):467-9. doi: 10.1001/jama.1954.02950050007002.

The effects of sex steroid and corticosteroid hormones on bone.性类固醇激素和皮质类固醇激素对骨骼的影响。

J Steroid Biochem. 1981 Dec;15:171-4. doi: 10.1016/0022-4731(81)90272-7.

Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment.类风湿关节炎患者的全身钙含量：疾病活动度及皮质类固醇治疗的影响

Br Med J (Clin Res Ed). 1982 Jul 31;285(6338):330-2. doi: 10.1136/bmj.285.6338.330.

Bone histomorphometric reproducibility in normal patients.正常患者骨组织形态计量学的可重复性

Calcif Tissue Int. 1981;33(4):369-74. doi: 10.1007/BF02409458.

Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man.奥沙唑酮和泼尼松对人体矿物质代谢的亚急性效应比较。

Calcif Tissue Int. 1980;31(2):109-15. doi: 10.1007/BF02407171.

Immobilization and bone.固定与骨骼

Calcif Tissue Int. 1983 May;35(3):265-7. doi: 10.1007/BF02405043.

Clinical equivalence of a new glucocorticoid, deflazacort and prednisone in rheumatoid arthritis and S.L.E. patients.

Adv Exp Med Biol. 1984;171:241-56.

Steroids possessing nitrogen atoms. 3. Synthesis of new highly active corticoids. [17-alpha, 16-alpha-d]oxazolino steroids.含氮原子的类固醇。3. 新型高活性皮质激素的合成。[17-α, 16-α-d]恶唑啉类固醇。

J Med Chem. 1967 Sep;10(5):799-802. doi: 10.1021/jm00317a009.

Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroids.类风湿关节炎的骨质疏松症：年龄、性别及皮质类固醇的影响

Arthritis Rheum. 1967 Oct;10(5):423-30. doi: 10.1002/art.1780100504.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验